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Background: Critical limb ischemia (CLI) is a terminal stage of peripheral arterial disease (PAD), in the absence 
of intervention, may lead to lower extremity amputation or death. In cases where medical management is not 
effective or severe cases of PAD, endovascular and surgical interventions are indicated. Endovascular interven-
tions have become the first-line approach of CLI management and advanced considerably within the past decade.
Case Description: A 78 years old patient with hypertension was admitted to the hospital with persistent chest 
discomfort and cough for two weeks. The CT aortic angiogram showed type B dissection. Based on the recent 
guidelines, TEVAR should be considered in patients with uncomplicated type B aortic dissection. Thus we 
prepared the patient for TEVAR procedure. First, we established a multidisciplinary vascular team for the pre-pro-
cedural preparation of the patient. We perform careful measurement through detailed CT angiography 
reconstruction from carotid to femoral arteries. We found proximal diameter was 30-35mm, the distal diameter 
was 23mm, and the landing zone right after the left brachial ostium, suitable for stent-graft Valiant Captivia 
36-32x150mm. The CT also showed that both the femoral artery were normal. We decided to use the right 
femoral artery as access. We proceed to the procedure two days later, under general anaesthesia, digital subtrac-
tion angiography revealed dissection of the descending aorta, and the selected device was inserted. Total 
occlusion of the primary intimal tear was revealed due to the subsequent contrast injection. The patient was 
transferred to ICU for postprocedural care and extubated the day after. The hospital stay was uneventful, and a 
one-month follow-up CT shows no endoleak.
Conclusion: Management of uncomplicated Stanford B dissections is very challenging. TEVAR has emerged as an 





 Dissection of the aorta is an uncommon yet devastating 
condition presented with a broad spectrum of clinical presentations. 
Population studies in the United States have estimated the incidence of 
aortic dissection to range from 2 to 3.5 cases per 100,000 persons per 
year.1 Aortic dissection is often associated with aging, obesity, collagen 
vascular disease, etc. Due to the wide range of initial symptoms and the 
physical examinations that were not specific, the use of CT, MRI, TEE, 
or occasionally, intrusive aortography is needed in diagnosing aortic 
dissection.
 
 An aortic dissection occurred when blood flow in a false 
lumen between the medial and the intimal layers of the aortic wall 
resulted from an intimal tear.2 The two major classifications for the 
dissection of the aorta, which based on the dissection location are the 
DeBakey classification and the Stanford classification (Figure 1). Aorta 
distal to the left subclavian artery was involved in DeBakey III or also 
known as Stanford type B dissection without any retrograde extension 
into the ascending aorta. Whereas in Stanford A and De Bakey I and II, 
there is the involvement of ascending aorta.3,4 Based on the onset, 
presentation occurs within 14 days is classified as acute, while chronic 
is more than two weeks.5,6 A recent publication from the IRAD study 
introduced a new classification for dissection, which stated that 
symptoms onset that lasts for more than 30 days is considered as 
chronic.7,8
 
 Stanford Type B aortic dissections account for 25% to 40% of 
all dissections.9 The mortality rate is 11.7%, with most deaths occurring 
in the first 24 hours.10 Type B aortic dissections (TBAD) can be either 
complicated or uncomplicated. The following symptoms define compli-
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or extremity, early aortic dilatation or signs of rupture or impending 
rupture (i.e., haemothorax, increasing periaortic and mediastinal 
hematoma), refractory pain and hypertension despite optimal medica-
tion, or retrograde aortic dissection. When patients are asymptomatic 
without pain or malperfusion signs and hemodynamically stable, the 
dissection is defined as uncomplicated, constituting 75% of TBAD.11,12
 Uncomplicated type B aortic dissection (UTBAD) has been 
treated conservatively with optimal medical therapy to reduce blood 
pressure and heart rate. Despite the success of UTBAD optimal medical 
management in the early phase, aortic degeneration and aneurysmal 
development of the dissected aorta remain as a clinical problem with 
the morbidity, including the aneurysm degeneration of the affected 
segment, of 30% with 10% of 5-year mortality rate.13,14 Due to these 
results, endovascular therapy was introduced. The thoracic endovascu-
lar aortic repair (TEVAR) of TBAD has created a paradigm shift to both 
preventing and treating those complications, instead of only treating 
the complications of TBAD. We present the case of a 78-year-old gentle-
man who presented with acute UTBAD managed by TEVAR.
Figure 1. Classification of Aortic Dissection. 17
2. Case illustrator
 A 78 years-old hypertensive patient admitted to the hospital 
with persistent chest discomfort and cough for two weeks. Initially, he 
was admitted for suspicion of pneumonia and scheduled for a chest 
x-ray by a pulmonologist. The CXR result (Figure 2) showed widened 
mediastinum with the conclusion suspected aortic dissection and 
pleural effusion on his left lung. He was then scheduled for a thorax 
ultrasound the next day. His ultrasound result showed minimal pleural 
effusion on his left lung, and due to suspicion of dissection aorta in the 
CXR, the radiologist decided to evaluate the abdominal aorta and found 
an intraluminal intimal flap in aorta abdominalis. Given these results, 
the patient was consulted to the cardiology department and underwent 
full echocardiography study, aortic duplex sonography examination, 
and CT aortic angiography the next day. Echocardiography showed 
mild aortic regurgitation, and the aortic duplex sonography revealed 
dilatation of the descendent aorta with a size of 2.97 x 3.97 cm and 
intimal flap in the abdominal aorta at the T5 level. CT aortic angiogra-
phy showed TBAD from descending aorta until supra-aortic bifurcation, 
with the main entry tear is renal, renal, 20-22 mm from the left subcla-
vian artery. The maximum diameter of the descending aorta was 6.52 
cm, with a false patent lumen, and the size of the false lumen was 2.64 
cm. It also showed another re-entry tear later at the distal part of the 
descending aorta (Figure 3). At the time of his clinical presentation, he 
complained of abdominal and back discomfort that 
persisted and rated with VAS 3-4 over 10. His was hemodynamically 
stable, and there was no sign of malperfusion syndrome, rupture, or 
impending rupture. Based on all of these findings patient was planned 
for TEVAR procedure for acute UTBAD. 
3. Pre-procedural Preparation
 We prepared this patient with our multidisciplinary vascular 
team and performed detailed CT aortic angiography reconstruction to 
choose the landing zone and the most suitable device for the patient.We 
found proximal diameter was 30-35mm, the distal diameter was 23mm, 
and the landing zone based on the intimal tear location was at the 
descending part of the aorta, after the left subclavian artery branch, 
suitable for stent-graft Valiant Captivia 36-32x150mm. The CT also 
showed that both the femoral artery were normal. We decided to use 
the right femoral artery for access (Figure 5).
4. Procedur
 The patient was taken to the catheterization lab and prepped 
and draped in the usual sterile manner from neck to knees. The patient 
undergoes general anaesthesia. Digital subtraction angiography was 
performed with access from the right common femoral artery. The 
digital subtraction angiography (DSA) revealed the ascending aorta in 
a proximal location still intact. The DSA showed intimal tear was on the 
descending part of the aorta with a landing zone distal to the left 
subclavian artery (Figure 6). Based on the measurement and the 
landing zone, the device graft was inserted and deployed. Subsequent 
contrast injection revealed total occlusion of a primary intimal tear 
(Figure 7). Extravasation of contrast outside the lumen was not found. 
The patient was transferred to the ICU for post-procedural care and 
extubated on the same day. The rest of the hospital stay was uneventful. 
The patient was discharged two days after the procedure, without any 
residual chest discomfort.
Figure 2. CXR results showing suspicion of dilatation of the Aorta
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Figure 3. CT Results
Figure 4. 3D CT reconstruction showing proximal to the distal landing zone.
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5. Follow up
 The patient came for a routine controlled each month. CT 
aortic angiogram evaluation performed one month after the procedure 
shows patent graft and no endoleak (Figure 8). The false lumen diame-
ter was reduced to 20 mm with thrombus in the false lumen. The 
patient was planned to undergo another serial follow-up CT aortic 
angiogram in the next three months, six months, and every year. The 
patient was also informed to continue anti-hypertensive drugs routine-
ly. The patient no longer complained about the chest discomfort, and 




 TEVAR is a safe, minimally invasive procedure, widely used 
as an alternative to surgery due to the lower morbidity and mortality 
rates in selected patient groups. The rationale for TEVAR for the 
management of TBAD is to promote primary closure in entry tear, 
which ultimately leads to false lumen thrombosis by decreasing 
pressure in the false lumen. It also prevents aortic events at the chronic 
phase, such as aneurysmal formation and rupture.6
 TEVAR was initially used as an alternative to surgery for 
complicated Stanford B dissections, including signs of thoracic aorta 
rupture, organ malperfusion, or rapid expansion of the dissection in the 
distal aortic arch or the descending aorta. Later on, it has been shown 
that due to a better aortic remodelling process, TEVAR also improves 
long-term survival in patients with uncomplicated dissections.15 Based 
on the latest ESC guidelines on the diagnosis and treatment of aortic 
diseases, TEVAR should be considered in the setting of UTBAD.16
 Patient selection who gain the advantage of UTBAD interven-
tion remains as the key to maximize the benefits in aortic repair and 
reduce the complications. Certain high-risk features that should prompt 
repair of an acute, uncomplicated TBAD has been looked at by several 
authors. These high-risk factors are as follows: intramural hematoma 
with penetrating aortic ulcer in the proximal descending thoracic aorta, 
initial aortic diameter > 4 cm with a false patent lumen, initial false 
lumen diameter > 22 mm in the proximal descending thoracic aorta, 
and recurrent or refractory pain or uncontrolled hypertension with 
optimal medical therapy.11 Our patient's initial aortic diameter was 6.52 
cm, and his initial false lumen was patent with a diameter of 2.64 cm, 
with an intimal tear in the proximal of descending aorta, which was a 
high-risk anatomic factor; the repair should have been considered at 
that time.
 Better clinical outcome was found in Endovascular stenting 
of dissections rather than conservative treatment. The possible mecha-
nism is likely due to the change in volume and remodelling process that 
occurred after a stent is deployed. Our patient's final DSA showed 
complete closure of intimal tear, thus reducing the false lumen's diame-
ter and thrombosis. It was confirmed by a 1-month CT follow-up that 
showed a patent stent with reduced false lumen to diameter 20 mm  
Figure 5. Digital Subtraction Angiography showed a dissection plane 
with a large false lumen.
Figure 6. DSA revealed total occlusion of the false lumen.
Figure 4. 3D CT reconstruction showing proximal to the distal landing 
zone.
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and no endoleaks. 
7. Conclusion
 
 When managed medically, UTBAD, a highly complicated 
disease process, is correlated with poor late outcomes in a sub-group of 
patients who are at risk. Its management remains a challenge in 
medical practice. With improved skills and equipment, endovascular 
percutaneous treatment with TEVAR emerged as an alternative to 
surgery with lower morbidity and mortality rates. The first trials' results 
are encouraging, suggesting that TEVAR ver effectively promotes a 
successful aortic remodelling in acute and subacute TBAD, which may 
be associated with reduced aorta-related complications and better 
survivals.
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